nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—Dactinomycin—testicular cancer	0.0889	0.284	CbGbCtD
Cilazapril—ABCB1—Vinblastine—testicular cancer	0.0557	0.178	CbGbCtD
Cilazapril—ABCB1—Cisplatin—testicular cancer	0.051	0.163	CbGbCtD
Cilazapril—ABCB1—Etoposide—testicular cancer	0.0501	0.16	CbGbCtD
Cilazapril—ABCB1—Doxorubicin—testicular cancer	0.0342	0.109	CbGbCtD
Cilazapril—ABCB1—Methotrexate—testicular cancer	0.0331	0.106	CbGbCtD
Cilazapril—ACE—vein—testicular cancer	0.0328	0.414	CbGeAlD
Cilazapril—ACE—embryo—testicular cancer	0.0062	0.0785	CbGeAlD
Cilazapril—ACE—seminal vesicle—testicular cancer	0.00582	0.0737	CbGeAlD
Cilazapril—SLC15A2—seminal vesicle—testicular cancer	0.00508	0.0643	CbGeAlD
Cilazapril—ACE—gonad—testicular cancer	0.00421	0.0533	CbGeAlD
Cilazapril—ACE—female gonad—testicular cancer	0.00342	0.0433	CbGeAlD
Cilazapril—ACE—testis—testicular cancer	0.00303	0.0384	CbGeAlD
Cilazapril—SLC15A2—female gonad—testicular cancer	0.00298	0.0377	CbGeAlD
Cilazapril—SLC15A2—testis—testicular cancer	0.00265	0.0335	CbGeAlD
Cilazapril—ACE—lymph node—testicular cancer	0.0022	0.0278	CbGeAlD
Cilazapril—ABCB1—embryo—testicular cancer	0.00218	0.0276	CbGeAlD
Cilazapril—ABCB1—seminal vesicle—testicular cancer	0.00205	0.0259	CbGeAlD
Cilazapril—SLC15A2—lymph node—testicular cancer	0.00192	0.0243	CbGeAlD
Cilazapril—ABCB1—gonad—testicular cancer	0.00148	0.0187	CbGeAlD
Cilazapril—ABCB1—female gonad—testicular cancer	0.0012	0.0152	CbGeAlD
Cilazapril—ABCB1—testis—testicular cancer	0.00107	0.0135	CbGeAlD
Cilazapril—ABCB1—lymph node—testicular cancer	0.000774	0.00979	CbGeAlD
Cilazapril—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000574	0.000944	CcSEcCtD
Cilazapril—Rash—Dactinomycin—testicular cancer	0.000574	0.000944	CcSEcCtD
Cilazapril—Decreased appetite—Etoposide—testicular cancer	0.000573	0.000942	CcSEcCtD
Cilazapril—Diarrhoea—Ifosfamide—testicular cancer	0.000571	0.000939	CcSEcCtD
Cilazapril—Renal failure—Epirubicin—testicular cancer	0.000569	0.000936	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Etoposide—testicular cancer	0.000569	0.000936	CcSEcCtD
Cilazapril—Fatigue—Etoposide—testicular cancer	0.000568	0.000934	CcSEcCtD
Cilazapril—Pain—Etoposide—testicular cancer	0.000564	0.000927	CcSEcCtD
Cilazapril—Constipation—Etoposide—testicular cancer	0.000564	0.000927	CcSEcCtD
Cilazapril—Conjunctivitis—Epirubicin—testicular cancer	0.000563	0.000926	CcSEcCtD
Cilazapril—Dysuria—Doxorubicin—testicular cancer	0.000562	0.000924	CcSEcCtD
Cilazapril—Neutropenia—Doxorubicin—testicular cancer	0.000562	0.000924	CcSEcCtD
Cilazapril—Pollakiuria—Doxorubicin—testicular cancer	0.000555	0.000913	CcSEcCtD
Cilazapril—Dizziness—Ifosfamide—testicular cancer	0.000552	0.000907	CcSEcCtD
Cilazapril—Pharyngitis—Methotrexate—testicular cancer	0.000551	0.000907	CcSEcCtD
Cilazapril—Urinary tract disorder—Methotrexate—testicular cancer	0.000549	0.000902	CcSEcCtD
Cilazapril—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000549	0.000902	CcSEcCtD
Cilazapril—Hepatobiliary disease—Epirubicin—testicular cancer	0.000548	0.000901	CcSEcCtD
Cilazapril—Epistaxis—Epirubicin—testicular cancer	0.000546	0.000899	CcSEcCtD
Cilazapril—Urethral disorder—Methotrexate—testicular cancer	0.000545	0.000896	CcSEcCtD
Cilazapril—Sinusitis—Epirubicin—testicular cancer	0.000543	0.000894	CcSEcCtD
Cilazapril—Feeling abnormal—Etoposide—testicular cancer	0.000543	0.000893	CcSEcCtD
Cilazapril—Hyperglycaemia—Doxorubicin—testicular cancer	0.000542	0.000892	CcSEcCtD
Cilazapril—Nausea—Dactinomycin—testicular cancer	0.000541	0.00089	CcSEcCtD
Cilazapril—Agranulocytosis—Epirubicin—testicular cancer	0.00054	0.000889	CcSEcCtD
Cilazapril—Gastrointestinal pain—Etoposide—testicular cancer	0.000539	0.000886	CcSEcCtD
Cilazapril—Visual impairment—Methotrexate—testicular cancer	0.000535	0.000881	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000531	0.000874	CcSEcCtD
Cilazapril—Vomiting—Ifosfamide—testicular cancer	0.00053	0.000873	CcSEcCtD
Cilazapril—Hypersensitivity—Cisplatin—testicular cancer	0.00053	0.000872	CcSEcCtD
Cilazapril—Bradycardia—Epirubicin—testicular cancer	0.000529	0.000871	CcSEcCtD
Cilazapril—Renal failure—Doxorubicin—testicular cancer	0.000527	0.000866	CcSEcCtD
Cilazapril—Rash—Ifosfamide—testicular cancer	0.000526	0.000865	CcSEcCtD
Cilazapril—Dermatitis—Ifosfamide—testicular cancer	0.000526	0.000864	CcSEcCtD
Cilazapril—Erythema multiforme—Methotrexate—testicular cancer	0.000525	0.000864	CcSEcCtD
Cilazapril—Urticaria—Etoposide—testicular cancer	0.000523	0.000861	CcSEcCtD
Cilazapril—Rhinitis—Epirubicin—testicular cancer	0.000521	0.000857	CcSEcCtD
Cilazapril—Abdominal pain—Etoposide—testicular cancer	0.000521	0.000857	CcSEcCtD
Cilazapril—Conjunctivitis—Doxorubicin—testicular cancer	0.000521	0.000857	CcSEcCtD
Cilazapril—Tinnitus—Methotrexate—testicular cancer	0.000518	0.000852	CcSEcCtD
Cilazapril—Hypoaesthesia—Epirubicin—testicular cancer	0.000517	0.000851	CcSEcCtD
Cilazapril—Asthenia—Cisplatin—testicular cancer	0.000516	0.000849	CcSEcCtD
Cilazapril—Pharyngitis—Epirubicin—testicular cancer	0.000516	0.000849	CcSEcCtD
Cilazapril—Cardiac disorder—Methotrexate—testicular cancer	0.000516	0.000848	CcSEcCtD
Cilazapril—Urinary tract disorder—Epirubicin—testicular cancer	0.000513	0.000845	CcSEcCtD
Cilazapril—Urethral disorder—Epirubicin—testicular cancer	0.00051	0.000838	CcSEcCtD
Cilazapril—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000507	0.000834	CcSEcCtD
Cilazapril—Epistaxis—Doxorubicin—testicular cancer	0.000505	0.000831	CcSEcCtD
Cilazapril—Angiopathy—Methotrexate—testicular cancer	0.000504	0.000829	CcSEcCtD
Cilazapril—Sinusitis—Doxorubicin—testicular cancer	0.000503	0.000827	CcSEcCtD
Cilazapril—Immune system disorder—Methotrexate—testicular cancer	0.000502	0.000825	CcSEcCtD
Cilazapril—Visual impairment—Epirubicin—testicular cancer	0.000501	0.000824	CcSEcCtD
Cilazapril—Agranulocytosis—Doxorubicin—testicular cancer	0.0005	0.000823	CcSEcCtD
Cilazapril—Chills—Methotrexate—testicular cancer	0.000498	0.00082	CcSEcCtD
Cilazapril—Nausea—Ifosfamide—testicular cancer	0.000496	0.000815	CcSEcCtD
Cilazapril—Diarrhoea—Cisplatin—testicular cancer	0.000492	0.000809	CcSEcCtD
Cilazapril—Erythema multiforme—Epirubicin—testicular cancer	0.000492	0.000809	CcSEcCtD
Cilazapril—Alopecia—Methotrexate—testicular cancer	0.000491	0.000808	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—testicular cancer	0.00049	0.000806	CcSEcCtD
Cilazapril—Hypersensitivity—Etoposide—testicular cancer	0.000485	0.000799	CcSEcCtD
Cilazapril—Tinnitus—Epirubicin—testicular cancer	0.000485	0.000797	CcSEcCtD
Cilazapril—Flushing—Epirubicin—testicular cancer	0.000483	0.000794	CcSEcCtD
Cilazapril—Cardiac disorder—Epirubicin—testicular cancer	0.000483	0.000794	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—testicular cancer	0.000482	0.000793	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—testicular cancer	0.000479	0.000787	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—testicular cancer	0.000477	0.000785	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—testicular cancer	0.000475	0.000781	CcSEcCtD
Cilazapril—Dysgeusia—Methotrexate—testicular cancer	0.000474	0.000779	CcSEcCtD
Cilazapril—Asthenia—Etoposide—testicular cancer	0.000473	0.000778	CcSEcCtD
Cilazapril—Angiopathy—Epirubicin—testicular cancer	0.000472	0.000776	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—testicular cancer	0.000472	0.000776	CcSEcCtD
Cilazapril—Immune system disorder—Epirubicin—testicular cancer	0.00047	0.000772	CcSEcCtD
Cilazapril—Chills—Epirubicin—testicular cancer	0.000467	0.000767	CcSEcCtD
Cilazapril—Pruritus—Etoposide—testicular cancer	0.000466	0.000767	CcSEcCtD
Cilazapril—Arrhythmia—Epirubicin—testicular cancer	0.000464	0.000764	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—testicular cancer	0.000464	0.000763	CcSEcCtD
Cilazapril—Alopecia—Epirubicin—testicular cancer	0.000459	0.000756	CcSEcCtD
Cilazapril—Vomiting—Cisplatin—testicular cancer	0.000457	0.000752	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—testicular cancer	0.000455	0.000748	CcSEcCtD
Cilazapril—Rash—Cisplatin—testicular cancer	0.000454	0.000746	CcSEcCtD
Cilazapril—Dermatitis—Cisplatin—testicular cancer	0.000453	0.000745	CcSEcCtD
Cilazapril—Diarrhoea—Etoposide—testicular cancer	0.000451	0.000742	CcSEcCtD
Cilazapril—Ill-defined disorder—Methotrexate—testicular cancer	0.000449	0.000738	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—testicular cancer	0.000449	0.000738	CcSEcCtD
Cilazapril—Anaemia—Methotrexate—testicular cancer	0.000447	0.000735	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—testicular cancer	0.000446	0.000734	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—testicular cancer	0.000446	0.000734	CcSEcCtD
Cilazapril—Flatulence—Epirubicin—testicular cancer	0.000446	0.000734	CcSEcCtD
Cilazapril—Tension—Epirubicin—testicular cancer	0.000444	0.000731	CcSEcCtD
Cilazapril—Dysgeusia—Epirubicin—testicular cancer	0.000443	0.000729	CcSEcCtD
Cilazapril—Nervousness—Epirubicin—testicular cancer	0.00044	0.000723	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—testicular cancer	0.000436	0.000718	CcSEcCtD
Cilazapril—Malaise—Methotrexate—testicular cancer	0.000436	0.000717	CcSEcCtD
Cilazapril—Dizziness—Etoposide—testicular cancer	0.000436	0.000717	CcSEcCtD
Cilazapril—Muscle spasms—Epirubicin—testicular cancer	0.000435	0.000716	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—testicular cancer	0.000435	0.000715	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—testicular cancer	0.000435	0.000715	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—testicular cancer	0.000433	0.000712	CcSEcCtD
Cilazapril—Chills—Doxorubicin—testicular cancer	0.000432	0.00071	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—testicular cancer	0.00043	0.000707	CcSEcCtD
Cilazapril—Nausea—Cisplatin—testicular cancer	0.000427	0.000703	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—testicular cancer	0.000425	0.000699	CcSEcCtD
Cilazapril—Cough—Methotrexate—testicular cancer	0.000422	0.000694	CcSEcCtD
Cilazapril—Ill-defined disorder—Epirubicin—testicular cancer	0.00042	0.000691	CcSEcCtD
Cilazapril—Vomiting—Etoposide—testicular cancer	0.000419	0.000689	CcSEcCtD
Cilazapril—Anaemia—Epirubicin—testicular cancer	0.000418	0.000688	CcSEcCtD
Cilazapril—Rash—Etoposide—testicular cancer	0.000415	0.000683	CcSEcCtD
Cilazapril—Dermatitis—Etoposide—testicular cancer	0.000415	0.000683	CcSEcCtD
Cilazapril—Headache—Etoposide—testicular cancer	0.000413	0.000679	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—testicular cancer	0.000413	0.000679	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—testicular cancer	0.000412	0.000677	CcSEcCtD
Cilazapril—Arthralgia—Methotrexate—testicular cancer	0.000412	0.000677	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—testicular cancer	0.000412	0.000677	CcSEcCtD
Cilazapril—Tension—Doxorubicin—testicular cancer	0.000411	0.000676	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—testicular cancer	0.00041	0.000675	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000409	0.000673	CcSEcCtD
Cilazapril—Malaise—Epirubicin—testicular cancer	0.000408	0.000671	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—testicular cancer	0.000407	0.000669	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—testicular cancer	0.000407	0.000669	CcSEcCtD
Cilazapril—Vertigo—Epirubicin—testicular cancer	0.000407	0.000669	CcSEcCtD
Cilazapril—Syncope—Epirubicin—testicular cancer	0.000406	0.000668	CcSEcCtD
Cilazapril—Leukopenia—Epirubicin—testicular cancer	0.000405	0.000666	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—testicular cancer	0.000403	0.000662	CcSEcCtD
Cilazapril—Palpitations—Epirubicin—testicular cancer	0.0004	0.000658	CcSEcCtD
Cilazapril—Confusional state—Methotrexate—testicular cancer	0.000398	0.000655	CcSEcCtD
Cilazapril—Loss of consciousness—Epirubicin—testicular cancer	0.000398	0.000654	CcSEcCtD
Cilazapril—Cough—Epirubicin—testicular cancer	0.000395	0.00065	CcSEcCtD
Cilazapril—Nausea—Etoposide—testicular cancer	0.000391	0.000644	CcSEcCtD
Cilazapril—Hypertension—Epirubicin—testicular cancer	0.000391	0.000643	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—testicular cancer	0.000389	0.000639	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—testicular cancer	0.000387	0.000637	CcSEcCtD
Cilazapril—Thrombocytopenia—Methotrexate—testicular cancer	0.000386	0.000636	CcSEcCtD
Cilazapril—Myalgia—Epirubicin—testicular cancer	0.000385	0.000634	CcSEcCtD
Cilazapril—Chest pain—Epirubicin—testicular cancer	0.000385	0.000634	CcSEcCtD
Cilazapril—Arthralgia—Epirubicin—testicular cancer	0.000385	0.000634	CcSEcCtD
Cilazapril—Anxiety—Epirubicin—testicular cancer	0.000384	0.000632	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—testicular cancer	0.000383	0.000631	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000383	0.000629	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—testicular cancer	0.000382	0.000628	CcSEcCtD
Cilazapril—Discomfort—Epirubicin—testicular cancer	0.000381	0.000626	CcSEcCtD
Cilazapril—Malaise—Doxorubicin—testicular cancer	0.000378	0.000621	CcSEcCtD
Cilazapril—Dry mouth—Epirubicin—testicular cancer	0.000377	0.00062	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—testicular cancer	0.000376	0.000619	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—testicular cancer	0.000376	0.000619	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—testicular cancer	0.000376	0.000618	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—testicular cancer	0.000375	0.000617	CcSEcCtD
Cilazapril—Confusional state—Epirubicin—testicular cancer	0.000372	0.000613	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—testicular cancer	0.00037	0.000609	CcSEcCtD
Cilazapril—Oedema—Epirubicin—testicular cancer	0.000369	0.000608	CcSEcCtD
Cilazapril—Hypotension—Methotrexate—testicular cancer	0.000369	0.000607	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—testicular cancer	0.000368	0.000605	CcSEcCtD
Cilazapril—Cough—Doxorubicin—testicular cancer	0.000365	0.000601	CcSEcCtD
Cilazapril—Shock—Epirubicin—testicular cancer	0.000363	0.000598	CcSEcCtD
Cilazapril—Thrombocytopenia—Epirubicin—testicular cancer	0.000362	0.000595	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—testicular cancer	0.000362	0.000595	CcSEcCtD
Cilazapril—Tachycardia—Epirubicin—testicular cancer	0.000361	0.000593	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00036	0.000591	CcSEcCtD
Cilazapril—Skin disorder—Epirubicin—testicular cancer	0.000359	0.00059	CcSEcCtD
Cilazapril—Hyperhidrosis—Epirubicin—testicular cancer	0.000357	0.000587	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—testicular cancer	0.000357	0.000587	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—testicular cancer	0.000357	0.000586	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—testicular cancer	0.000357	0.000586	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—testicular cancer	0.000357	0.000586	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—testicular cancer	0.000355	0.000584	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—testicular cancer	0.000354	0.000583	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000354	0.000582	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—testicular cancer	0.000352	0.000579	CcSEcCtD
Cilazapril—Anorexia—Epirubicin—testicular cancer	0.000352	0.000579	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—testicular cancer	0.000352	0.000579	CcSEcCtD
Cilazapril—Somnolence—Methotrexate—testicular cancer	0.000351	0.000577	CcSEcCtD
Cilazapril—Dry mouth—Doxorubicin—testicular cancer	0.000349	0.000574	CcSEcCtD
Cilazapril—Dyspepsia—Methotrexate—testicular cancer	0.000347	0.000571	CcSEcCtD
Cilazapril—Hypotension—Epirubicin—testicular cancer	0.000345	0.000568	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—testicular cancer	0.000345	0.000567	CcSEcCtD
Cilazapril—Decreased appetite—Methotrexate—testicular cancer	0.000343	0.000564	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—testicular cancer	0.000342	0.000562	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000341	0.00056	CcSEcCtD
Cilazapril—Fatigue—Methotrexate—testicular cancer	0.00034	0.00056	CcSEcCtD
Cilazapril—Pain—Methotrexate—testicular cancer	0.000338	0.000555	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000337	0.000554	CcSEcCtD
Cilazapril—Shock—Doxorubicin—testicular cancer	0.000336	0.000553	CcSEcCtD
Cilazapril—Thrombocytopenia—Doxorubicin—testicular cancer	0.000335	0.00055	CcSEcCtD
Cilazapril—Insomnia—Epirubicin—testicular cancer	0.000334	0.00055	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—testicular cancer	0.000334	0.000549	CcSEcCtD
Cilazapril—Skin disorder—Doxorubicin—testicular cancer	0.000332	0.000546	CcSEcCtD
Cilazapril—Paraesthesia—Epirubicin—testicular cancer	0.000332	0.000546	CcSEcCtD
Cilazapril—Hyperhidrosis—Doxorubicin—testicular cancer	0.00033	0.000543	CcSEcCtD
Cilazapril—Dyspnoea—Epirubicin—testicular cancer	0.000329	0.000542	CcSEcCtD
Cilazapril—Somnolence—Epirubicin—testicular cancer	0.000328	0.00054	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—testicular cancer	0.000326	0.000536	CcSEcCtD
Cilazapril—Feeling abnormal—Methotrexate—testicular cancer	0.000325	0.000535	CcSEcCtD
Cilazapril—Dyspepsia—Epirubicin—testicular cancer	0.000325	0.000535	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methotrexate—testicular cancer	0.000323	0.000531	CcSEcCtD
Cilazapril—Decreased appetite—Epirubicin—testicular cancer	0.000321	0.000528	CcSEcCtD
Cilazapril—Hypotension—Doxorubicin—testicular cancer	0.000319	0.000525	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000319	0.000525	CcSEcCtD
Cilazapril—Fatigue—Epirubicin—testicular cancer	0.000318	0.000524	CcSEcCtD
Cilazapril—Constipation—Epirubicin—testicular cancer	0.000316	0.00052	CcSEcCtD
Cilazapril—Pain—Epirubicin—testicular cancer	0.000316	0.00052	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—testicular cancer	0.000314	0.000516	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—testicular cancer	0.000312	0.000513	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000311	0.000512	CcSEcCtD
Cilazapril—Insomnia—Doxorubicin—testicular cancer	0.000309	0.000508	CcSEcCtD
Cilazapril—Paraesthesia—Doxorubicin—testicular cancer	0.000307	0.000505	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—testicular cancer	0.000305	0.000501	CcSEcCtD
Cilazapril—Feeling abnormal—Epirubicin—testicular cancer	0.000304	0.000501	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—testicular cancer	0.000304	0.0005	CcSEcCtD
Cilazapril—Gastrointestinal pain—Epirubicin—testicular cancer	0.000302	0.000497	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—testicular cancer	0.000301	0.000495	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—testicular cancer	0.000297	0.000489	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000295	0.000485	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—testicular cancer	0.000295	0.000485	CcSEcCtD
Cilazapril—Urticaria—Epirubicin—testicular cancer	0.000293	0.000483	CcSEcCtD
Cilazapril—Pain—Doxorubicin—testicular cancer	0.000292	0.000481	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—testicular cancer	0.000292	0.000481	CcSEcCtD
Cilazapril—Abdominal pain—Epirubicin—testicular cancer	0.000292	0.00048	CcSEcCtD
Cilazapril—Hypersensitivity—Methotrexate—testicular cancer	0.000291	0.000478	CcSEcCtD
Cilazapril—Asthenia—Methotrexate—testicular cancer	0.000283	0.000466	CcSEcCtD
Cilazapril—Feeling abnormal—Doxorubicin—testicular cancer	0.000282	0.000463	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000279	0.00046	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—testicular cancer	0.000279	0.000459	CcSEcCtD
Cilazapril—Hypersensitivity—Epirubicin—testicular cancer	0.000272	0.000448	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—testicular cancer	0.000272	0.000447	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—testicular cancer	0.00027	0.000444	CcSEcCtD
Cilazapril—Diarrhoea—Methotrexate—testicular cancer	0.00027	0.000444	CcSEcCtD
Cilazapril—Asthenia—Epirubicin—testicular cancer	0.000265	0.000436	CcSEcCtD
Cilazapril—Pruritus—Epirubicin—testicular cancer	0.000261	0.00043	CcSEcCtD
Cilazapril—Dizziness—Methotrexate—testicular cancer	0.000261	0.000429	CcSEcCtD
Cilazapril—Diarrhoea—Epirubicin—testicular cancer	0.000253	0.000416	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—testicular cancer	0.000252	0.000414	CcSEcCtD
Cilazapril—Vomiting—Methotrexate—testicular cancer	0.000251	0.000413	CcSEcCtD
Cilazapril—Rash—Methotrexate—testicular cancer	0.000249	0.000409	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—testicular cancer	0.000249	0.000409	CcSEcCtD
Cilazapril—Headache—Methotrexate—testicular cancer	0.000247	0.000407	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—testicular cancer	0.000245	0.000403	CcSEcCtD
Cilazapril—Dizziness—Epirubicin—testicular cancer	0.000244	0.000402	CcSEcCtD
Cilazapril—Pruritus—Doxorubicin—testicular cancer	0.000242	0.000398	CcSEcCtD
Cilazapril—Vomiting—Epirubicin—testicular cancer	0.000235	0.000386	CcSEcCtD
Cilazapril—Nausea—Methotrexate—testicular cancer	0.000234	0.000386	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—testicular cancer	0.000234	0.000385	CcSEcCtD
Cilazapril—Rash—Epirubicin—testicular cancer	0.000233	0.000383	CcSEcCtD
Cilazapril—Dermatitis—Epirubicin—testicular cancer	0.000233	0.000383	CcSEcCtD
Cilazapril—Headache—Epirubicin—testicular cancer	0.000231	0.000381	CcSEcCtD
Cilazapril—Dizziness—Doxorubicin—testicular cancer	0.000226	0.000372	CcSEcCtD
Cilazapril—Nausea—Epirubicin—testicular cancer	0.000219	0.000361	CcSEcCtD
Cilazapril—Vomiting—Doxorubicin—testicular cancer	0.000217	0.000357	CcSEcCtD
Cilazapril—Rash—Doxorubicin—testicular cancer	0.000215	0.000354	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—testicular cancer	0.000215	0.000354	CcSEcCtD
Cilazapril—Headache—Doxorubicin—testicular cancer	0.000214	0.000352	CcSEcCtD
Cilazapril—Nausea—Doxorubicin—testicular cancer	0.000203	0.000334	CcSEcCtD
